Biomedical Firm Signs Pact With Japanese
- Share via
GARDEN GROVE — MicroProbe Corp., a biomedical company, said it signed an agreement with a Japanese firm to jointly develop a diagnostic system that could be used to identify diseases.
Terms of the agreement with Tokyo-based Olympus Optical Co. Ltd. were not disclosed. The companies plan to use their technology to create a machine that can quickly identify the genetic makeup of infectious diseases and cancers.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
